Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE

Objectives  To estimate the times from HIV seroconversion to death, and to the initiation of therapy and the mean CD4 cell count at initiation.

[1]  N. Low,et al.  Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. , 1999, AIDS.

[2]  R. Brettle,et al.  Do gender differences in CD4 cell counts matter? , 1999, AIDS.

[3]  C. Sabin,et al.  Immune markers and viral load after HIV‐1 seroconversion as predictors of disease progression in a cohort of haemophilic men , 1998, AIDS.

[4]  P. Vanhems,et al.  Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  D. Vlahov,et al.  Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion , 1996, BMJ.

[6]  S M Gore,et al.  Progression of HIV: follow‐up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983–1985 , 1996, AIDS.

[7]  C. Rouzioux,et al.  High risk of HIV disease progression after infection through a sexual partner with AIDS , 1996, AIDS.

[8]  J. Montoro,et al.  An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patients. , 1995, Blood.

[9]  A. Karlsson,et al.  Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 × 106/l, AIDS, and death from AIDS? , 1994, BMJ.

[10]  C. Swanson,et al.  Development of AIDS in a cohort of HIV‐seropositive homosexual men in Australia , 1990, The Medical journal of Australia.

[11]  E. Scheibel,et al.  Clinical course of primary HIV infection: consequences for subsequent course of infection. , 1989, BMJ.

[12]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.

[13]  J. Goudsmit,et al.  Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. , 1988, AIDS.

[14]  J. Goudsmit,et al.  Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. , 1987, American journal of epidemiology.

[15]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[16]  S. Pérez-Hoyos,et al.  [AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort]. , 1999, Gaceta sanitaria.

[17]  J. Koch,et al.  Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. , 1993, AIDS.

[18]  P. Krijnen,et al.  Predictors of rapid progression to AIDS in HIV-1 seroconverters. , 1993, AIDS.

[19]  J Elford,et al.  More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. , 1991, Journal of acquired immune deficiency syndromes.

[20]  K. Skaug,et al.  The early introduction of HIV infection among Norwegians at highest risk. , 1990, Scandinavian journal of infectious diseases.

[21]  P. J. Huber.  The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .

[22]  D.,et al.  Regression Models and Life-Tables , 2022 .